The estimated Net Worth of Frank H Laukien is at least $2.55 mil millones dollars as of 26 October 2023. Frank Laukien owns over 59,523 units of Bruker Corp stock worth over $2,452,603,025 and over the last 21 years he sold BRKR stock worth over $94,716,463. In addition, he makes $4,909,640 as Chairman of the Board, President y Chief Executive Officer at Bruker Corp.
Frank has made over 104 trades of the Bruker Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 59,523 units of BRKR stock worth $2,746,986 on 26 October 2023.
The largest trade he's ever made was buying 1,000,000 units of Bruker Corp stock on 15 June 2015 worth over $19,500,000. On average, Frank trades about 56,188 units every 50 days since 2003. As of 26 October 2023 he still owns at least 38,327,911 units of Bruker Corp stock.
You can see the complete history of Frank Laukien stock trades at the bottom of the page.
Dr. Frank H. Laukien Ph.D. serves as Chairman of the Board, President, Chief Executive Officer of the Company. Dr. Laukien has been our Chairman, President and Chief Executive Officer since February 1991 and is our largest stockholder. Dr. Laukien also serves as a director of various subsidiaries of Bruker, none of which are publicly-traded companies. Dr. Laukien served as a director of ALDA (Analytical, Life Science & Diagnostics Association), an industry association formerly known as Analytical & Life Sciences Systems Association, or ALSSA, for several terms in the past, and was ALSSA Chairman from 2002 to 2003. Dr. Laukien holds a Bachelor of Science degree in physics from the Massachusetts Institute of Technology ("MIT"), as well as a Ph.D. in chemical physics from Harvard University. Dr. Laukien was a member of the Dean's Advisory Committee of the MIT School of Science until 2014, and a Trustee of the Rivers School in Weston, Massachusetts until 2013. In May 2017, Dr. Laukien was elected a senator of acatech, the German National Academy of Science and Engineering. As our largest stockholder and based on his long history of leading the profitable growth at Bruker, Dr. Laukien brings to the Board the perspective of a significant stakeholder with an in-depth knowledge of all aspects of our operations. He also provides extensive executive experience in organizational management, strategic planning, finance, global business development and life science tools markets, as well as the scientific and technical background required for a deep understanding of our key technologies, markets and industry dynamics.
As the Chairman of the Board, President y Chief Executive Officer of Bruker Corp, the total compensation of Frank Laukien at Bruker Corp is $4,909,640. There are no executives at Bruker Corp getting paid more.
Frank Laukien is 60, he's been the Chairman of the Board, President y Chief Executive Officer of Bruker Corp since 1991. There are 14 older and 7 younger executives at Bruker Corp. The oldest executive at Bruker Corp is Marc Kastner, 74, who is the Independent Director.
Frank's mailing address filed with the SEC is C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA, MA, 01821.
Over the last 21 years, insiders at Bruker Corp have traded over $527,877,336 worth of Bruker Corp stock and bought 5,273,190 units worth $50,472,973 . The most active insiders traders include Joerg C Laukien, Isolde Laukien y Marc M Laukien. On average, Bruker Corp executives and independent directors trade stock every 36 days with the average trade being worth of $16,426,809. The most recent stock trade was executed by Bob Rosenthal on 15 August 2024, trading 12,500 units of BRKR stock currently worth $292,125.
right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www
Bruker Corp executives and other stock owners filed with the SEC include: